Literature DB >> 17950108

Leptin secretory burst mass correlates with body mass index and insulin in normal women but not in women with polycystic ovary syndrome.

Maria J Iuorno1, Leila Z Islam, Paula P Veldhuis, David G Boyd, Leon S Farhy, Michael L Johnson, John E Nestler, William S Evans.   

Abstract

Leptin secretion exhibits a pulsatile, circadian pattern and may play a role in reproduction. No previous studies have compared leptin secretory burst characteristics in normal eumenorrheic women and women with polycystic ovary syndrome (PCOS) who are appropriately matched for body mass index (BMI). To determine if leptin secretory burst characteristics and/or the relationships of BMI, insulin, or testosterone to these characteristics differ between PCOS and normal women, we studied 9 normal eumenorrheic women and 9 women with PCOS. Each woman underwent blood sampling every 10 minutes for 24 hours to measure leptin and insulin under controlled conditions. Leptin secretory bursts were identified and characterized using multiparameter deconvolution procedures (Deconv), and the 24-hour periodicity of leptin was characterized with cosinor analysis. Relationships between BMI, area under the curve (AUC) insulin, and testosterone and leptin secretory burst characteristics in PCOS and normal women were sought using linear regression. There were no significant differences in mean serum leptin concentrations or in secretory burst characteristics between PCOS and normal women. Although the 24-hour serum leptin concentration correlated with BMI in both normal and PCOS women, leptin secretory burst mass correlated with BMI only in normal women. Similarly, the 24-hour serum leptin concentration correlated with serum insulin AUC in both normal and PCOS women; but insulin AUC correlated with leptin burst mass only in normal women. Although there was a strong trend toward a correlation between both mean 24-hour serum leptin concentration and leptin secretory burst mass with the serum testosterone concentration in normal women, such trends were not seen in PCOS women. Both normal and PCOS women exhibited a diurnal rhythm of leptin secretion with the peak occurring at night. However, neither the peak amplitude nor the timing of the peak amplitude differed between normal and PCOS women. The presence of strong relationships between BMI and insulin with both mean serum leptin and leptin secretory burst mass in normal women as opposed to PCOS women suggests that the mechanisms subserving leptin secretion differ in these 2 groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950108     DOI: 10.1016/j.metabol.2007.06.027

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum.

Authors:  Charumathi Baskaran; Kamryn T Eddy; Karen K Miller; Erinne Meenaghan; Madhusmita Misra; Elizabeth A Lawson
Journal:  Eur J Endocrinol       Date:  2016-04       Impact factor: 6.664

Review 2.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

3.  "Association of Leptin with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis".

Authors:  Mahesh Kumar Seth; Sarthak Gulati; Shreya Gulati; Amit Kumar; Dimple Rawat; Aradhana Kumari; Rohini Sehgal; Rinchen Zangmo; Vivek Dixit; Arti Gulati
Journal:  J Obstet Gynaecol India       Date:  2021-08-04

4.  Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.

Authors:  Mark A Lawson; Sonia Jain; Shelly Sun; Ketan Patel; Pamela J Malcolm; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 5.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

6.  Serum leptin changes with metformin treatment in polycystic ovarian syndrome: correlation with ovulation, insulin and testosterone levels.

Authors:  Prerna Upadhyaya; H S Rehan; Vikas Seth
Journal:  EXCLI J       Date:  2011-02-24       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.